GENOPLEX MAP RCC-3Plex

Payment

WK
MOQ

1 Unit
Supply Details

Customization

1unit= 1kit
Country of sale

Asia, Europe
Catalogue
PRICE
- FOB
  
  Depend on quantity

Description
Shipping&Payments
Company Introduction
POC SUGGESTIONS
(PROOF OF CONCEPT)
Product Reviews

ITEM SPECIFICS

Brand

GENOPLEX MAP

Model RCC-3Plex
origin

Republic of Korea
Size(Capacity)

1 Kit
Function

A simple antibody-based blood test designed to detect kidney cancer
Features

In vitro Kidney Cancer Diagnostics, Luminex MAP-based multiplex Assay

PRODUCT DESCRIPTION

Renal cell carcinoma (RCC) is the third most common urological malignancy and one of the most refractory malignancies due to a metastasis rate of up to 25% at presentation and the lack of a curative therapy. Generally, RCC is highly resistant to conventional chemotherapy and radiation therapy and the mortality from RCC exceeds 100,000 per year worldwide.
GENOMINE Inc. offers the GenoPlexMAP Human Renal Cell Carcinoma detection kit. The Cancer Biomarker Panel includes 3-Plex assay, which simultaneously measures three serum biomarkers, Nicotinamide N- metyltransferase (NNMT), Non-metastatic cells 1 (NM23A) and L-plastin (LCP1).

The combination of the three serum biomarkers that discriminate between disease-free and Renal Cell Carcinoma patients was characterized and validated by GENOMINE Inc. and Yonsei University Medical School. Using a scoring algorithm, the profile of three biomarkers in circulation was used to detect all stages of Renal Cell Carcinoma patients with high sensitivity and accuracy. The assays can be used to quantify these biomarkers in serum, plasma.

PAYMENTS DETAILS

This supplier supports payments for offline orders

Contact Payment Manager

Name : Sera Park

SHIPPING

Shipping from : Republic of Korea

394 Jigok-ro Nam-gu, Pohang-si, Gyeongsangbuk-do (37668)

Can't find a valid Shipping method for supplier account. Please contact the pertaining representative for detailed information.

GENOMINE,INC

genomine.com

The person in charge
Dong Su Kim
Address
394 Jigok-ro Nam-gu, Pohang-si, Gyeongsangbuk-do (37668)

Introduction

GENOMINE is a company focused on the discovery, development and commercialization of biomarkers and diagnostic kits for early detection of cancers. GENOMINE has been working on a full range of services to support various proteome-related researches from separation and identification of proteins to analysis of post-translational modifications such as phosphorylation and glycosylation. We have well equipped proteomics core facility and our staff scientists are experienced proteomics professionals. GENOMINE is dedicated to the development of in vitro antibody-based assays for a select group of cancers that are difficult to accurately diagnose without resorting

Business Type :

Manufacturer
Main Product :

Disease Diagnosis Kit
Established :

1999-09-09
Total Annual Revenue :

1~2 billion (KRW)
Total Employees :

5~10 people